NASDAQ: ACRS
Aclaris Therapeutics Inc Stock Ownership - Who owns Aclaris Therapeutics?

Insider buying vs selling

Have Aclaris Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Roland Wilhelm KolbeckCSci2026-08-0112,385$5.20
$64.40kSell
Jesse Wayne HallChief Medical Officer2026-05-019,330$4.41
$41.15kSell
Braden Michael Leonard10% Owner2026-04-23300,000$4.53
$1.36MSell
Kevin BalthaserChief Financial Officer2026-03-01677$2.87
$1.94kSell
Neal WalkerCEO2026-02-0318,611$3.47
$64.58kSell
Kevin BalthaserChief Financial Officer2026-02-036,449$3.47
$22.38kSell
James LoeropChief Business Officer2026-02-035,937$3.47
$20.60kSell
Kevin BalthaserChief Financial Officer2026-02-014,984$3.51
$17.49kSell
James LoeropChief Business Officer2026-02-0110,686$3.51
$37.51kSell
James LoeropChief Business Officer2026-01-026,171$2.88
$17.77kSell

1 of 2

ACRS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACRS insiders and whales buy or sell their stock.

ACRS Shareholders

What type of owners hold Aclaris Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Braden Michael Leonard26.63%42,243,975$165.60MInsider
Fmr LLC5.45%8,637,727$33.86MInsider
Ra Capital Management LP2.74%4,339,299$17.01MInsider
Albert Cha2.64%4,191,397$16.43MInsider
Anand Mehra2.63%4,177,456$16.38MInsider
James E. Flynn2.60%4,123,266$16.16MInsider
Vivo Ventures VII LLC1.80%2,858,569$11.21MInsider
Sofinnova Venture Partners VIII LP1.44%2,289,480$8.97MInsider
Neal Walker0.97%1,543,886$6.05MInsider
Foresite Capital Management III LLC0.79%1,258,243$4.93MInsider

1 of 3

ACRS vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACRS0.05%49.68%Net Selling
FLGT0.03%48.48%Net SellingNet Selling
MYGN0.06%11.79%Net SellingNet Selling
CSTL0.06%14.92%Net SellingNet Selling
BNR0.00%18.08%Net Buying

Aclaris Therapeutics Stock Ownership FAQ

Who owns Aclaris Therapeutics?

Aclaris Therapeutics (NASDAQ: ACRS) is owned by 0.05% institutional shareholders, 49.68% Aclaris Therapeutics insiders, and 50.28% retail investors. Braden Michael Leonard is the largest individual Aclaris Therapeutics shareholder, owning 42.24M shares representing 26.63% of the company. Braden Michael Leonard's Aclaris Therapeutics shares are currently valued at $165.60M.

If you're new to stock investing, here's how to buy Aclaris Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.